September 22, 2022
The national GRADE study, with leadership and participation from UNC School of Medicine's John Buse, MD, PhD, and Sue Kirkman, MD, found that two of four common type 2 diabetes treatments -- glargine and liraglutide -- worked better than the other drugs, sitagliptin and glimepiride, to maintain blood glucose levels.
August 31, 2022
UNC School of Medicine’s 55th annual Student Research Day will take place on Friday, Nov. 11. The John B. Graham Research Society is seeking faculty judges to help make the day a success by providing formative feedback to student presenters.
August 17, 2022
The Women’s Irritability, Stress, and Estrogen Study aims to understand the biological mechanisms underlying the relationship between estrogen changes and increased irritability during the menopause transition.
August 9, 2022
The Doris Duke Charitable Foundation awarded more than $7.9 million in grants to 16 early-career physician scientists, including two from the UNC School of Medicine – Andrea Knittel, MD, PhD and Peyton Thompson, MD.
July 27, 2022
The UNC site lead investigators are Michelle Hernandez, MD, professor in the UNC Department of Pediatrics, and Katrina Donahue, MD, MPH, professor and vice chair of research in the UNC Department of Family Medicine.
July 5, 2022
The Clinical Trials Unit in the UNC Children’s Research Institute is a site for a national study to assess the efficacy of Paxlovid, a pill to treat COVID in children under 18 at increased risk for severe illness.
May 10, 2022
James F. Howard, MD, Distinguished Professor of Neuromuscular Disease, Professor of Neurology, Medicine and Allied Health in the UNC School of Medicine, was lead investigator in the Phase 3 clinical trial of zilucoplan.
April 19, 2022
This virtual seminar series will provide a background in the use of machine learning tools to answer clinical questions, understand the strengths and limitations of these methods, and examine real-world examples of machine learning methodology in clinical research. The series is co-sponsored by the UNC Core Center for Clinical Research and the UNC Program for Precision Medicine in Health Care.
April 11, 2022
Sarah Kowitt, PhD, MPH, Adam Goldstein, MD, MPH, and Samuel Cykert, MD, recently published a study that found a cardiovascular disease risk reduction intervention improved rates of tobacco screening and cessation support in small primary care practices in North Carolina.
April 6, 2022
James F. Howard Jr., MD, professor in the UNC Department of Neurology, was principal investigator of the ADAPT+ trial for the experimental drug efgartigimod, developed by Belgian pharmaceutical company Argenx.
March 29, 2022
The department's spring newsletter includes stories on the UNC COVID Recovery Clinic, views from the new Acute Inpatient Rehab center in Hillsborough, and new faculty members and advanced practice providers.
March 22, 2022
A UNC Maternal-Fetal Medicine Network trial has shown that, among pregnant and postpartum individuals, SARS-CoV-2 infection was associated with increased risk of maternal mortality or serious morbidity from obstetric complications.